Related Experiment Video
Updated: Jul 10, 2025
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention
Yousef M Al-Saraireh1, Fatemah O F O Alshammari2, Omar H Abu-Azzam3
1Department of Pharmacology, Faculty of Medicine, Mutah University, P.O. Box 7, Al-Karak 61710, Jordan.
Abstract:
Over the past decade, there have been significant developments in treatment for ovarian cancer, yet the lack of targeted therapy with few side effects still represents a major issue. The cytochrome P450 (CYP) enzyme family plays a vital role in the tumorigenesis process and metabolism of drugs and has a negative impact on therapy outcomes. Gaining more insight into CYP expression is crucial to understanding the pathophysiology of ovarian cancer since many isoforms are essential to the metabolism of xenobiotics and steroid hormones, which drive the disease's development. To the best of our knowledge, no review articles have documented the intratumoral expression of CYPs and their implications in ovarian cancer. Therefore, the purpose of this review is to provide a clear understanding of differential CYP expression in ovarian cancer and its implications for the prognosis of ovarian cancer patients, together with the effects of CYP polymorphisms on chemotherapy metabolism. Finally, we discuss opportunities to exploit metabolic CYP expression for the development of novel therapeutic methods to treat ovarian cancer.
Insights
This review explores cytochrome P450 (CYP) enzyme expression in ovarian cancer, highlighting their role in disease progression and chemotherapy metabolism. Understanding CYP expression offers potential for targeted ovarian cancer therapies with fewer side effects.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Ovarian cancer treatment lacks targeted therapies with minimal side effects.
- Cytochrome P450 (CYP) enzymes are crucial in tumorigenesis and drug metabolism, impacting treatment outcomes.
- Intratumoral CYP expression is vital for understanding ovarian cancer pathophysiology, including xenobiotic and steroid hormone metabolism.
Purpose of the Study:
- To review differential CYP expression in ovarian cancer.
- To elucidate the implications of CYP expression on patient prognosis.
- To examine the impact of CYP polymorphisms on chemotherapy metabolism and discuss therapeutic opportunities.
Main Methods:
- Comprehensive literature review of studies on CYP expression in ovarian cancer.
- Analysis of existing data on CYP isoforms involved in ovarian cancer.
- Synthesis of information regarding CYP polymorphisms and their clinical relevance.
Main Results:
- CYP enzymes exhibit differential expression patterns in ovarian tumors.
- Specific CYP isoforms are linked to ovarian cancer progression and patient prognosis.
- CYP polymorphisms influence the metabolism of various chemotherapeutic agents.
Conclusions:
- Understanding intratumoral CYP expression is critical for improving ovarian cancer treatment strategies.
- Targeting CYP enzymes or accounting for their polymorphisms may lead to personalized chemotherapy regimens.
- Further research into CYP-driven metabolic pathways can unlock novel therapeutic targets for ovarian cancer.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...